TrialInternational journal of hematology2017

Bendamustine plus rituximab for previously untreated patients with indolent B-cell non-Hodgkin lymphoma or mantle cell lymphoma: a multicenter Phase II clinical trial in Japan.

Michinori Ogura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.